AMENDMENT NO. 1 TO AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2024 ISSUED BY QIAGEN FINANCE (LUXEMBOURG) S.A.Qiagen Nv • April 2nd, 2007 • Biological products, (no disgnostic substances) • New York
Company FiledApril 2nd, 2007 Industry Jurisdiction
AMENDMENT NO. 1 TO AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2026 ISSUED BY QIAGEN EURO FINANCE (LUXEMBOURG) S.A.Qiagen Nv • April 2nd, 2007 • Biological products, (no disgnostic substances) • New York
Company FiledApril 2nd, 2007 Industry Jurisdiction
INTERCOMPANY AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2026 ISSUED BY QIAGEN EURO FINANCE (LUXEMBOURG) S.A.Intercompany Agreement • April 2nd, 2007 • Qiagen Nv • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 2nd, 2007 Company Industry Jurisdiction